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Quantifying the risks of radiation exposure
H. J. WASSERMAN
Summary
The considerations leading to the recommendation
of dose-equivalent limits by the International Com-
mission for Radiological Protection are outlined. The
dose-equivalent limits are based. on radiation risk
factors estimated from effects of radiation observed
over many decades. These limits are designed to
ensure that radiation exposure does not entail a
greater risk than that experienced in other safe occu-
pations or accepted by the general public in everyday
life. The risk factors should, however, not be used to
assess the risk to patients from diagnostic pro-
cedures.
S AIr Med J 1986: 70: 333-336.
The commissioning of the Koeberg nuclear power station
during 1984 has created in the public an awareness of and
interest in the risks due to radiation exposure. Concern has
been expressed about the level of knowledge possessed by
medical practitioners of the risks due to radiation exposure. I
Recently the Atomic Energy Corporation (AEC) of South
Africa issued document NKKS 10/822 in which revised dose-
equivalent* limits for radiation workers were laid down. These
latest dose-equivalent limits were based on the recommenda-
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-For radiation protection purposes, the radiation received by tissue is quamified in terms of
the dose equivalent. its SI unit is the sievert ($\'). 1 Sv = 100 rem.
tions of the International Commission for Radiological Protec-
tion (ICRP)Y
It is thus appropriate to review briefly the present state of
knowledge of risks from radiation, as compiled by the ICRP,
and to outline the considerations leading to the laying down of
dose-equivalent limits for radiation workers and the general
public.
International Commission for Radiological
Protection (ICRP)
The ICRP was established in 1928 as the International X-ray
and Radium Protection Commission by the Second Interna-
tional Congress of Radiology held in Stockholm, Sweden. It
assumed its present name in 1950, and functions under the
auspices of the International Congress of Radiology. The
Commission consists of a Chairman and not more than 12
members. The selection of members is made by the ICRP
from nominations submitted to it by the national delegations
to the International Congress of Radiology and by the ICRP
itself. The selections are subject to approval by the Interna-
tional Executive Committee of the Congress. Members of the
ICRP are chosen on the basis of their recognized activity in
the fields of medical radiology, radiation protection, physics,
health physics, biology, genetics, biochemistry and biophysics
with regard to an appropriate balance of expertise rather than
to nationality. Not less than 3 but not more than 5 members
are changed at anyone Congress.
The ICRP may invite individuals to give special technical
advice, and may also establish such committees as it deems
necessary to perform its functions. Much of the work is
performed by ad hoc task groups, by means of which the
Commission has been able to call on the services of a large
number of individuals who are not members of a committee.
The Commission has regularly published reports and recom-
mendations. These are now available in the form of a review
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TABLE I. RISK FACTORS FOR RADIATION-INDUCED
STOCHASTIC EFFECTS3
journal, Annals of rhe ICRP, published by Pergamon Press,
Oxford.
Recommendations of the ICRP (publication
No. 26)
Recommended limits of radiation dose
tissue is responsible for more than one-fifth of this value. It is
recognized that the risk factors vary with age and sex, but the
variations with age and sex in total risk from an individual
exposure are not considerable. The weighting factors listed in
document NKKS 10/822 are simply the ratios between the
risk factors of the various organs and the total stochastic risk
factor, 16,5 x 10-3 Sv- I, obtained by summing all the risk
factors (omining the additional hereditary damage to later
generations).
For purposes of radiation protection of individuals, the
mortality risk factor for radiation-induced cancers is taken to
be about 10-2Sv-' (10-4 rem-I) as an average for both sexes and
all ages.
Regarding non-stochastic effects, it was concluded that a
total dose equivalent of 15 Sv would be below the threshold
for the production of any lens opacification that would interfere
with vision. (Later information indicated that this value was
somewhat high, and the recommended annual limits were
subsequently reduced.4 ) Skin is thought to be much less liable
to develop fatal cancer after irradiation than the tissues already
discussed. Limitation of the dose to the skin to below 20 Sv
over a lifetime should prevent cosmetically unacceptable
changes. Induction of permanent sterility would require several
Sv in both sexes. It is well known that exposure before birth
or during childhood may interfere with subsequent growth
and development. Susceptibility to induction of certain malig-
nancies is also higher than during adult life.
In the light of evidence from heavily irradiated populations
observed for periods up to 30 years, the ICRP concluded that
it is unlikely that any major hazard from radiation has been
overlooked.
Occupational exposure
The aim of radiation protection should be to prevent non-
stochastic effects and to limit the probability of stochastic
effects to levels deemed acceptable. The ICRP recommends
upper limits of exposure but recommends that no exposure be
unjustified in relation to its benefits and that any necessary
exposures are kept ~s low ~s reasonably ~chievable (the ALARA
principle).
Non-stochastic effects may be prevented by sening annual
dose-equivalent limits at sufficiently low values so that no
threshold dose would be reached, even following exposure for
the whole lifetime or total period of working life. These limits
are 0,5 Sv (50 rem) for all tissues except the lens of the eye for
which a limit of 0,15 Sv (15 rem) is recommended.
Regarding stochastic'effects resulting from occupational radi-
ation exposure, the Commission recommends upper limits of
radiation dose which will ensure that the calculated rate of
fatal malignancies induced by the radiation will be comparable
to the occupational fatality rate of industries recognized as
having high standards of safety. These are considered to be
those in which the annual mortality due to occupational
hazards does not exceed 10-4 deaths per person. Levels of risk
experienced in South Mrican industry are listed in Table II."
It must be realized that the rilOrtality figures for safe
occupations give the average risk for a worker, and that some
workers will be exposed to much higher risks. A similar
situation applies in radiation work. Experience has shown that
in circumstances where the ICRP's recommendation of an
annual dose-equivalent limit of 50 mSv (5 rem) has been
applied in large occupational groups, the arithmetic mean was
about 5 mSv (500 mrem) with very few values approaching the
limit. Multiplying the risk factor of 10-2 Sv- I by this mean
dose yields an average risk factor for radiation work which is
Risk factor
4,0 X 10-3 4,0 X 10·s
Sv I rem-I
2,5 x 10-3 2,5 x 10·'
2,0 X 10-3 2,0 X 10-s
2,0 X 10-3 2,0 X 10·s
5,0 X 10-4 5,0 X 10··
5,0 X 10-4 5,0 X 10-·
Effect
Breast cancer
Leukaemia
Lung cancer
Bone cancer
Thyroid cancer mortality
Combined risk of malignancy in
other unspecified tissues
Serious hereditary ill-health within
first two generations (irradiation of
either parent)
Additional hereditary damage to
later generations
The ICRP bases its recommendations on the radiation effects
(or absence of effects) observed over several decades. These
include, for example, reported data obtained from experiments
on animals and lower organisms, observations on humans
irradiated for therapeutic purposes, Japanese survivors of
nuclear explosions, miners in radioactive mines and radiation
workers.
It distinguishes between stochastic and non-stochastic effects.
Stochastic effects are effects for which the probability of an
effect occuring rather than its severity is regarded as depending
on the radiation dose. It is assumed that no 'safe' threshold
dose exists below which no such effects would occur. The
most important stochastic effects are carcinogenesis and heredi-
tary effects. (It should be pointed out that a latent period
which may vary from a few to 30 years or more may elapse
between the exposure to radiation and the occurrence of
cancer.5 The length of the latent period depends on the dose,
type of cancer and age of the individual.) Non-stochastic
effects are those for which the severity of the effect varies with
dose, and for which a theshold may occur. Examples of non-
stochastic effects are induction of cataract of the lens of the
eye, non-malignant damage to skin, and cell depletion in the
bone marrow leading to haematological deficiencies.
One basic assumption of the ICRP is that there is a linear
relationship without threshold between dose and probability of
a stochastic effect, within the range of exposure encountered
in radiation work.
From the aforesaid data the ICRP has estimated the proba-
bility of inducing fatal malignant disease, non-stochastic
diseases or substantial genetic defects in liveborn descendants.
This probability expressed per unit dose is termed the 'risk
factor'. The risk factor is the proportionality constant of the
relationship between dose and probability of an effect occur-
ring. Risk factors for those tissues from which the majority of
all induced malignancies appear likely to arise are listed in
Table I.
These risk factors are very similar to those reported in a
separate analysis by the United Nations Scientific Comminee
on Effects of Atomic Radiation (UNSCEAR) in 1977.5 Con-
cerning the combined risk of malignant disease in all remaining
unspecified tissues of 5 x 10-3 SV-I it is assumed that no single
TABLE 11. AVERAGE ANNUAL INDUSTRIAL FATALITY
RATESs*
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TABLE IV. ANNUAL AVERAGE FATALITY RATES FOR
GENERAL PUBLICS
was arrived at by adopting in effect a figure of 5 x 10-6 deaths
per person per year as the maximum acceptable fatality rate
and a radiation risk factor of 2 x 10-2 deaths per Sv (2 x 10-4
rem-I). It is estimated that the average risk in a group in which
this maximum may occur would be 50 times lower.6
Industrial class
Agriculture and forestry
Fishing
Mining
Building and construction
Food, drink, tobacco
Chemical
Trade, commerce
Banking, finance, insurance
Transport
Medical services
Professional services
*Six-year mean 1965 - 1970.
Deaths/ person /yr
3,28 x 10-4
2,33 X 10-3
8,35 X 10-4
7,68 X 10-4
2,27 X 10-4
2,49 X 10-4
1,73 X 10-4
6,78 X 10-5
1,00 X 10-3
4,25 X 10-5
4,75 X 10-5
Cause
Motor vehicles
Drowning
Railways
Lightning
Venomous insects
Deaths/ person /yr
3 x 10-4
6 X 10-5
1 X 10-5
2 X 10-6
2 X 10-6
comparable to the average risk in other safe industries.
Although the ICRP's dose-equivalent limits are intended to
ensure adequate protection even for the most higWy exposed
individuals a higher than average risk applies to an individual
consistently exposed to levels near the limit. Since the actual
risk decreases linearly with dose, the ALARA principle should
be applied at all times. Table III gives a summary of the dose-
equivalent limits laid down by the South Mrican AEC in
document NKKS 10/82, which are based on the recommenda-
tions of ICRP publication No. 26.
Individual members of the public
The general public is subject to a variety of hazards, for
example, public and private transport that contribute to the
total risk to which they are exposed. The acceptance of this
risk is motivated by certain benefits that may not otherwise be
received, by an assessment of the social cost of reducing the
risk, or by regarding the risk as negligible. Table IV lists some
annual average fatality rates for the general public in South
Mrica.6 .
The ICRP concluded that the level of acceptability for fatal
risks to the general public is an order of magnitude lower than
for occupational risks. Accordingly they recommend a whole-
body dose-equivalent limit of 5 mSv (0,5 rem) per year for
members of the public. An overriding dose-equivalent limit of
50 mSv to prevent non-stochastic effects should be applied.
This is considerably lower than that recommended for occupa~
tional exposure in order to ensure that the possible longer
exposure period and the practical difficulties in controlling the
total exposure from all sources will not result in threshold
doses for non-stochastic effects being reached.
In document NKKS 10/82 the AEC quotes as an example
that 0,25 mSv (25 mrem) has been laid down as the annual
upper limit of dose equivalent that an individual member of
the public may receive as result of normal releases of radio-
nuclides by the Koeberg nuclear power station.2 This figure
Patient exposures
When exposed to radiation during a medical examination,
the patient receives benefit from the procedure. Accordingly,
it is not appropriate to apply the dose-equivalent limits for
exposure of radiation workers or the general public to patient
exposures. With certain medical exposures a very much higher
level of risk may be justified than that deemed appropriate for
radiation workers or the general public. As a general principle,
the ICRP recommends that unnecessary exposures should be
avoided, necessary exposures should be justifiable in terms of
benefits that would not otherwise have been received, and that
the doses actually administered should be limited to the
minimum amount consistent with the medical benefit to the
individual patient. Nevertheless it is important that the danger
of radiation exposure should not be overestimated since this
might lead to the rejection of justified examinations.
The aim of radiation protection of the patient has gradually
shifted from a concern about population exposures and here-
ditary effects to the ambition of limiting the risk to the
individual patient.7 However, caution has been expressed
against a tendency to use the risk factors for predicting the
actual numbers of cases in any particular situation.8 The risk
factors should rather be regarded as upper estimates of risk,
based on experience mainly with external radiation at high
doses and dose rates and often with high linear energy transfer.9
Extrapolation to irradiation conditions used in clinical practice
might be too inaccurate to use them as criteria for comparing
the risk from different clinical procedures.
Factors such as differences in linear energy transfer, dose
and dose rate could cause the risk of certain diagnostic radiation
procedures to be lower.5 The length of the latent period
should also be considered in relation to the age of the patient.
evertheless the ICRP has used the risk factors to obtain an
'approximate estimation of the magnitude' of the risk of
fatality for x-ray chest examination of adult females (Table
V).7 This calculation illustrates a different approach from that
based on the critical tissue concept which the ICRP followed
TABLE Ill. DOSE-EQUIVALENT LIMITS AND DERIVED DOSE RATES FOR RADIATION
WORKERS'
Tissue
Whole body
Skin, extremities
Lens of eye
Annual limit
(mSv)
50 (5 rem)
500 (50 rem)
150 (15 rem)
Weekly average
(mSv)
1 (100 mrem)
10 (1 000 mrem)
3 (300 mrem)
Hourly average
(mSv)
0,025 (2,5 mrem)
0,25 (25 mrem)
0,075 (7,5 mrem)
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TABLE V. ESTIMATION OF RADIATION RISK TO ADULT FEMALES FOLLOWING TYPICAL
TISSUE DOSES* FROM AN X-RAY CHEST EXAMINATlON7
Organ, tissue
Lung
Breast
Bone marrow
Thyroid
Estimated mean
absorbed dose
(mSv)
0,20
0,14
0,03
0,07
Risk factor
(10-4 SV- I)
20
2 x 25
20
5
Radiation risk
(deaths per person
x 10-6)
0,40
0,70
0,06
0,04
;,Doses to other organs are negligible.
before 1977 and which is still followed by the United States
National Council on Radiation Protection and Measurements.
According to the critical tissues concept the dose equivalent to
an individual should be limited by that dose to an organ which
would result in the greatest detriment to the individual or
his/her progeny. 10 In the new ICRP approach the dose equiva-
lent should be limited by the total stochastic risk (if non-
stochastic effects may be excluded) obtained by summation of
the risks to all organs.7
Since the risk factors were largely obtained from external
irradiation of humans they might be especially inappropriate
for assessing risks from internal eminers lO as used in nuclear-
medicine procedures. Apart from the factors mentioned above,
the risks from internal eminers might be different due to non-
homogeneous distribution of activity at the cellular level
coupled with low-energy electron emission (e.g. iodine-125 11).
Certain observations lend support to the concept of microdosi-
metry, namely that the biological effectiveness of radiation
depends on the panern of energy deposition within microscopic
volumes having diameters of 1 nm - 1 Jlm. 12 It is known for
example" that 131 I is about 10 - 20 times less effective on a rem-
for-rem basis than x-ray therapy for ablating the thyroid.
Johnson and Myers ll showed that theory suggests that
differences in linear energy transfer and dose rate might cause
1311 to be 2-10 times less effective than x-rays at high dose
rate for induction of thyroid cancer in humans. They reviewed
data based on animal experiments and experience in humans,
but could not, however, find convincing evidence that there is
a great difference in the efficiency of I3l I and x-rays for
induction of thyroid cancer. Animal experiments suggested
that low doses of 1311 should be as efficient or at most three
times less efficient than x-rays for inducing thyroid cancer.
They quoted a large follow-up study conducted by Holm et al.
on patients who had received 131 I for diagnosis. No significant
increase in thyroid cancer had been found. A significant
increase would have been expected if a risk estimate of 100 x
10-4 Sv- I was used, but not if a value of 14 x 10-4 Sv- I was
used.
In summary then, the risk estimates of the ICRP are
conservative. 1O They thus provide a sound basis for radiation
protection in order to ensure that individuals are not exposed
to harmful amounts of radiation. They should, however, not
be used at present to predict actual numbers of deaths from
radiation from clinical diagnostic procedures.7 Decisions based
on overestimation of radiation risks could be to the detriment
of a patient if it should exclude him/her from the benefits of a
particular procedure.
The ALARA principle
It must be emphasized that dose-equivalent limits recom-
mended by regulating authorities are not intended to be
considered 'safe' doses, but are regarded as maximum permis-
sible levels. An overriding principle in recommendations is
that all radiation doses are to be kept ~s low !!s ,Eeasonably
!!chievable (the ALARA principle). Careful thought may be
required to establish what is reasonably achievable. For a
general discussion of relevant cost-benefit analysis the reader
is referred to ICRP publication No. 26.3 However, it must be
pointed out that in weighing the 'cost' of radiation exposure,
the hazards of alternative procedures must be considered. It
would be wrong to restrict radiation exposure to such a level
that an alternative more hazardous procedure has to be
ad·opted.
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